Filed: 5/14/2025ACC: 0000950142-25-001365
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $2.98B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$2.98B
Total AUM (reported)
217.41M
Total Shares
Allocation by class
COM$1.73B57.9%
CL A$1.07B35.9%
ADS$182.47M6.1%
Portfolio Concentration
Top 3$2.08B69.7%
4–10$858.44M28.8%
11–25$44.67M1.5%
Top 3 weight
69.7%
Top 10 weight
98.5%
Voting Authority Distribution
Total shares with voting rights: 217.41M
Sole
Full voting authority
217.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
ALIGNMENT HEALTHCARE
SOLEShares60.99M
TypeSH
Market value$1.14B
38.12%
Sole
60.99M
Shared
0.00
None
0.00
DLOCAL
SOLEShares63.91M
TypeSH
Market value$532.98M
17.89%
Sole
63.91M
Shared
0.00
None
0.00
XP, INC
SOLEShares29.62M
TypeSH
Market value$407.24M
13.67%
Sole
29.62M
Shared
0.00
None
0.00
ALKAMI
SOLEShares9.65M
TypeSH
Market value$253.19M
8.50%
Sole
9.65M
Shared
0.00
None
0.00
AKERO THERAPEUTICS
SOLEShares5.23M
TypeSH
Market value$211.87M
7.11%
Sole
5.23M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares9.68M
TypeSH
Market value$139.22M
4.67%
Sole
9.68M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares7.53M
TypeSH
Market value$118.24M
3.97%
Sole
7.53M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$51.79M
1.74%
Sole
13.11M
Shared
0.00
None
0.00
ROYALTY PHARMA
SOLEShares1.50M
TypeSH
Market value$46.70M
1.57%
Sole
1.50M
Shared
0.00
None
0.00
IMMUNOCORE
SOLEShares1.26M
TypeSH
Market value$37.43M
1.26%
Sole
1.26M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$24.60M
0.83%
Sole
5.32M
Shared
0.00
None
0.00
ACELYRIN
SOLEShares2.70M
TypeSH
Market value$6.66M
0.22%
Sole
2.70M
Shared
0.00
None
0.00
ADAGENE
SOLEShares3.83M
TypeSH
Market value$5.82M
0.20%
Sole
3.83M
Shared
0.00
None
0.00
WISH
SOLEShares609.62K
TypeSH
Market value$4.26M
0.14%
Sole
609.62K
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$3.34M
0.11%
Sole
2.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALIGNMENT HEALTHCARESOLE | COM | 60.99M | SH | $1.14B 38.12% | 60.99M | 0.00 | 0.00 |
DLOCALSOLE | CL A | 63.91M | SH | $532.98M 17.89% | 63.91M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 29.62M | SH | $407.24M 13.67% | 29.62M | 0.00 | 0.00 |
ALKAMISOLE | COM | 9.65M | SH | $253.19M 8.50% | 9.65M | 0.00 | 0.00 |
AKERO THERAPEUTICSSOLE | COM | 5.23M | SH | $211.87M 7.11% | 5.23M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | ADS | 9.68M | SH | $139.22M 4.67% | 9.68M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 7.53M | SH | $118.24M 3.97% | 7.53M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CL A | 13.11M | SH | $51.79M 1.74% | 13.11M | 0.00 | 0.00 |
ROYALTY PHARMASOLE | CL A | 1.50M | SH | $46.70M 1.57% | 1.50M | 0.00 | 0.00 |
IMMUNOCORESOLE | ADS | 1.26M | SH | $37.43M 1.26% | 1.26M | 0.00 | 0.00 |
RISKIFIEDSOLE | CL A | 5.32M | SH | $24.60M 0.83% | 5.32M | 0.00 | 0.00 |
ACELYRINSOLE | COM | 2.70M | SH | $6.66M 0.22% | 2.70M | 0.00 | 0.00 |
ADAGENESOLE | ADS | 3.83M | SH | $5.82M 0.20% | 3.83M | 0.00 | 0.00 |
WISHSOLE | CL A | 609.62K | SH | $4.26M 0.14% | 609.62K | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | CL A | 2.47M | SH | $3.34M 0.11% | 2.47M | 0.00 | 0.00 |